STRAIN A/17/Texas/2012/30 (H3N2) OF INFLUEZA VIRUS FOR PRODUCING INTRANASAL LIVE INFLUENZA VACCINE FOR ADULTS AND CHILDREN

摘要

FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to biotechnology, namely to the strain A/17/Texas/2012/30 (H3N2) of influenza virus. The given viral strain is deposited in the State Collection of Viruses of FGBU (Federal State Budgetary Institution) D.I. Ivanovskiy Scientific Research Institute of Virology of the Ministry of Health of Russia, under No. 2737.EFFECT: presented invention enables producing the new strain A/17/Texas/2012/30 (H3N2) of influenza virus, which is used to produce the intranasal live influenza vaccine for adults and children.4 tbl